Delivery Order SPE2DB20D3303-SPE2DB24FY8A8
Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.20 firm fixed price delivery order is for the supply of Risperdal 0.5 mg tablets, a pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, designated as SPE2DX. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,759.83 firm fixed-price delivery order contract is to supply Risperdal 1 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. While the original solicitation was not provided, the award indicates that it was not designated with any set-aside...
- This federal contract award, valued at $1,573.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 2 mg tablets. It is a Firm Fixed Price, Delivery Order type contract with a completion date of June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a $1,367.87 delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 1 mg tablets, a mental health medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.11 firm fixed-price delivery order is for the supply of Risperdal 0.5 mg tablets, with a completion date of November 16, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,062.01 Firm Fixed Price delivery order contract is for the supply of RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on July 16, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,397.16, is for the delivery of Risperdal 2 mg tablets. It is a firm-fixed-price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,382.54 firm fixed-price delivery order is for the supply of Risperdal 2 mg tablets, a medication commonly used for the treatment of mental health conditions. The contract, which has an ultimate completion date of September 29, 2022, is not designated as a set-aside. It is a child contract under a larger...
- This federal contract award, valued at $1,489.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RISPERDAL 1 MG TABLET UD 100S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and a firm fixed-price pricing type. No set-aside designation was used for this award. Amerisourcebergen holds a significant...